Caprock Group’s Merck MRK Stock Holding History

Caprock Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.17M	Sell	75,687 -1,731	-2%	-$200K	0.22%	71
2025 Q4	$8.21M	Buy	77,418 +14,031	+22%	+$1.32M	0.17%	95
2025 Q3	$5.33M	Buy	+63,387	New	+$5.22M	0.13%	131
2025 Q1	$6.07M	Sell	67,040 -3,608	-5%	-$337K	0.19%	92
2024 Q4	$7.08M	Buy	70,648 +1,573	+2%	+$162K	0.23%	68
2024 Q3	$7.9M	Sell	69,075 -2,895	-4%	-$344K	0.29%	61
2024 Q2	$8.97M	Buy	71,970 +20,927	+41%	+$2.7M	0.36%	46
2024 Q1	$6.77M	Buy	51,043 +2,398	+5%	+$296K	0.39%	44
2023 Q4	$5.34M	Buy	48,645 +15,922	+49%	+$1.65M	0.34%	48
2023 Q3	$3.39M	Buy	32,723 +1,142	+4%	+$123K	0.26%	59
2023 Q2	$3.67M	Buy	31,581 +2,146	+7%	+$244K	0.27%	57
2023 Q1	$3.15M	Buy	29,435 +733	+3%	+$79.1K	0.24%	67
2022 Q4	$3.21M	Buy	28,702 +2,141	+8%	+$219K	0.3%	51
2022 Q3	$2.31M	Buy	26,561 +894	+3%	+$79.8K	0.22%	67
2022 Q2	$2.36M	Buy	25,667 +1,009	+4%	+$89.5K	0.23%	63
2022 Q1	$2.04M	Buy	24,658 +1,578	+7%	+$124K	0.19%	85
2021 Q4	$1.79M	Sell	23,080 -12,167	-35%	-$969K	0.15%	102
2021 Q3	$2.67M	Sell	35,247 -37	-0.1%	-$2.81K	0.24%	63
2021 Q2	$2.77M	Buy	35,284 +3,539	+11%	+$263K	0.25%	64
2021 Q1	$2.35M	Sell	31,745 -7,589	-19%	-$560K	0.26%	66
2020 Q4	$3.1M	Buy	39,334 +3,940	+11%	+$301K	0.35%	46
2020 Q3	$2.82M	Sell	35,394 -698	-2%	-$54.7K	0.39%	45
2020 Q2	$2.68M	Buy	36,092 +4,065	+13%	+$306K	0.4%	45
2020 Q1	$2.37M	Buy	32,027 +14,851	+86%	+$1.17M	0.45%	41
2019 Q4	$1.5M	Sell	17,176 -115	-0.7%	-$9.45K	0.27%	74
2019 Q3	$1.4M	Buy	17,291 +1,328	+8%	+$106K	0.27%	70
2019 Q2	$1.28M	Sell	15,963 -10,684	-40%	-$818K	0.25%	76
2019 Q1	$2.13M	Buy	26,647 +2,734	+11%	+$204K	0.41%	48
2018 Q4	$1.76M	Buy	23,913 +2,821	+13%	+$199K	0.4%	49
2018 Q3	$1.44M	Sell	21,092 -550	-3%	-$35K	0.29%	62
2018 Q2	$1.26M	Sell	21,642 -10,687	-33%	-$603K	0.27%	66
2018 Q1	$1.7M	Sell	32,329 -3,584	-10%	-$194K	0.36%	48
2017 Q4	$2.01M	Sell	35,913 -6,305	-15%	-$350K	0.39%	48
2017 Q3	$2.6M	Buy	42,218 +1,013	+2%	+$61.4K	0.54%	32
2017 Q2	$2.54M	Sell	41,205 -1,808	-4%	-$110K	0.56%	31
2017 Q1	$2.61M	Buy	43,013 +2,594	+6%	+$157K	0.61%	31
2016 Q4	$2.27M	Sell	40,419 -15,212	-27%	-$890K	0.57%	32
2016 Q3	$3.31M	Buy	55,631 +1,157	+2%	+$67.7K	0.75%	25
2016 Q2	$2.99M	Sell	54,474 -936	-2%	-$49.8K	0.73%	35
2016 Q1	$2.8M	Buy	+55,410	New	+$2.71M	0.66%	31
2015 Q3	–	Sell	-3,856	Closed	-$209K	–	89
2015 Q2	$209K	Buy	+3,856	New	+$216K	0.19%	71

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caprock Group's MRK Position: Q1 2026 in Review

Caprock Group reduced its Merck (MRK) stake by 2.2% in Q1 2026, selling an estimated $200K and leaving 75,687 shares worth $9.17M. The position accounts for 0.22% of the portfolio, ranked #71.

Caprock Group first reported a position in MRK in Q2 2015 and has held it in 41 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Caprock Group held 75,687 shares of Merck worth $9.17M as of Q1 2026.
Caprock Group sold 1,731 Merck shares in Q1 2026, an estimated $200K.
Merck made up 0.22% of Caprock Group's portfolio in Q1 2026, its #71 holding.
Caprock Group first reported a position in Merck in Q2 2015 and has held it in 41 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.